-
Guest, the 'News in Brief' for the week beginning 18th January 2021 is here.Dismiss Notice
-
Welcome! To read the Core Purpose and Values of our forum, click here.Dismiss Notice
Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for [ME/CFS], 2020, Mitchell et al
Discussion in 'BioMedical ME/CFS Research' started by Andy, Oct 30, 2020.
Tags: